J. G. Fernández-Bolaños, G. Bosica, R. Ballini
FULL PAPER
1-(3,4-Dihydroxyphenyl)-N-methoxy-2-nitroethanamine (3e): Reac-
1
hexane, 1:2). Data for 6b: H NMR (500 MHz, CDCl3): δ = 7.50–
tion time 2 h; purification by column chromatography (hexane/
6.70 (m, 10 H, 2ϫPhH), 4.84 (m, 1 H, 5-H), 4.64 (d, J5,6 = 10.6 Hz,
EtOAc, 2:1); yield 565 mg, 75%; yellowish oil; Rf = 0.18 (hexane/ 1 H, 6-H), 4.37, 3.92 (2ϫd, J = 9.1 Hz, 1 H each, CH2Ph), 2.93
1
EtOAc, 2:1). H NMR (300 MHz, CDCl3): δ = 6.84–6.74 (m, 3 H, (br. s, 1 H, OH), 2.53 (dtd, J4a,4e = 14.0, J4a,3a = 12.4, J4a,5 = 12.4,
ArH), 5.59 (br. s, 3 H, 2ϫOH, NH), 4.83 (dd, J1,2a = 7.4, J2a,2b
12.1 Hz, 1 H, 2a-H), 4.66 (dd, J1,2b = 5.4 Hz, 1 H, 1-H), 4.55 (dd,
=
J4a,3e = 4.3 Hz, 1 H, 4a-H), 2.13 (m, 1 H, 4e-H), 2.09 (m, 1 H, 3e-
H), 1.85 (m, J3a,3e = 13.8 Hz, 1 H, 3a-H), 1.61 (s, 3 H, CH3) ppm.
J2b,1 = 5.4, J2b,2a = 12.1 Hz, 1 H, 2b-H), 3.52 (3 H, OCH3) ppm. 13C NMR (125.7 MHz, CDCl3): δ = 136.6, 135.4, 129.2, 128.9,
13C NMR (75.5 MHz, CDCl3): δ = 144.3, 144.0, 128.6, 120.5, 128.51, 128.46, 128.4 (2ϫPh), 88.4 (C-5), 87.1 (C-2), 78.3 (CH2Ph),
115.9, 114.8 (Ar), 78.1 (C-2), 62.9 (C-1), 62.6 (OCH3) ppm. IR
66.2 (C-6), 33.4 (C-3), 28.3 (CH3), 25.6 (C-4) ppm. Data for 7b: 1H
(KBr): νmax = 3320, 2953, 2921, 2847, 1717, 1553, 1445, 1379 cm–1. NMR (500 MHz, CDCl3): δ = 5.14 (td, J3,4e = 5.8, J3,4a = 9.2, J2,3
˜
MS (EI): m/z (%) = 228 (8) [M]+. HRMS (EI): calcd. for
= 9.2 Hz, 1 H, 3-H), 4.74 (m, 1 H, 5-H), 4.70 (d, J2,3 = 9.2 Hz, 1
H, 2-H), 4.32, 4.14 (2ϫd, J = 9.5 Hz, 1 H each, CH2Ph), 2.81 (m,
J4a,4e = 16.6, J4a,5 = 2.5, J4a,Me = 2.5 Hz, 1 H, 4a-H), 1.96 (m, 3
H, CH3) ppm. 13C NMR (125.7 MHz, CDCl3): δ = 100.3 (C-5),
83.5 (C-3), 78.1 (CH2Ph), 68.0 (C-2), 19.0 (C-4) ppm. IR (NaCl,
C9H12N2O5 [M]+ 228.0746; found 228.0757.
N-Benzyloxy-1-(3,4-dihydroxyphenyl)-2-nitroethanamine (3f): Reac-
tion time 2 h; purification by column chromatography (hexane/
EtOAc, 2:1); yield 823.4 mg, 82%; yellowish oil; Rf = 0.57 (CH2Cl2/
MeOH, 10:1). 1H NMR (300 MHz, CDCl3): δ = 7.38–7.26 (m, 5
H, PhH), 6.76–6.68 (m, 3 H, ArH), 5.84 (br. s, 3 H, 2ϫOH, NH),
4.78 (dd, J1,2a = 7.4, J2a,2b = 12.3 Hz, 1 H, 2a-H), 4.69, 4.65 (2ϫd,
J = 11.5 Hz, 1 H each, CH2Ph), 4.64 (dd, J1,2b = 5.5 Hz, 1 H, 1-
H), 4.49 (dd, J2b,1 = 5.5, J2b,2a = 12.3 Hz, 1 H, 2b-H) ppm. 13C
NMR (75.5 MHz, CDCl3): δ = 144.4, 144.0, 136.9, 128.9, 128.7,
128.4, 128.2, 120.5, 116.0, 114.9 (Ar, Ph), 78.4 (C-2), 77.1 (CH2Ph),
Nujol): ν
= 3583, 2924, 2855, 1738, 1558, 1458, 1376 cm–1. MS
˜
max
(EI): m/z (%) = 324 (4) [M]+. HRMS (EI) for 6b: calcd. for
C19H22N2O4 [M]+ 342.1580; found 324.1570.
(2R*,5S*,6R*)-6-(3,4-Dimethoxyphenyl)-1-methoxy-2-methyl-5-
nitropiperidin-2-ol (6c) and (2R*,3S*)-2-(3,4-Dimethoxyphenyl)-1-
methoxy-6-methyl-3-nitro-1,2,3,4-tetrahydropyridine (7c): Reac-
tion time 4 h; purification by column chromatography (EtOAc/hex-
ane, 1:4 Ǟ 1:3); yield 114 mg, 83%; colorless foam; 6c/7c ratio
86:14; Rf = 0.18 (EtOAc/hexane, 1:2). Data for 6c: 1H NMR
(300 MHz, CDCl3): δ = 7.00–6.80 (m, 3 H, ArH), 4.73 (m, 1 H, 5-
H), 4.46 (d, J5,6 = 10.4 Hz, 1 H, 6-H), 3.90, 3.87 (2ϫs, 3 H each,
2ϫArOCH3), 3.08 (s, 3 H, NOCH3), 2.88 (br. s, 1 H, OH), 2.49
(dtd, J4a,4e = 14.0, J4a,3a = 12.5, J4a,5 = 12.5, J4a,3e = 4.4 Hz, 1 H,
4a-H), 2.08 (m, 1 H, 4e-H), 2.02 (m, 1 H, 3e-H), 1.77 (m, 1 H, 3a-
H), 1.51 (s, 3 H, CH3) ppm. 13C NMR (75.5 MHz, CDCl3): δ =
149.2, 148.7, 128.9, 121.4, 111.8, 110.8 (Ar), 88.6 (C-5), 87.0 (C-2),
65.9 (C-6), 63.9 (NOCH3), 56.1, 56.0 (2ϫArOCH3), 33.3 (C-3),
28.1 (CH3), 25.5 (C-4) ppm. Data for 7c: 1H NMR (300 MHz,
CDCl3): δ = 5.06 (td, J3,4e = 5.7, J3,4a = 9.3, J3,2 = 9.3 Hz, 1 H, 3-
H), 4.73 (m, 1 H, 5-H), 4.53 (d, J2,3 = 9.3 Hz, 1 H, 2-H), 3.17 (s,
3 H, NOCH3), 2.80 (m, J4a,4e = 16.7, J4a,3 = 2.5, J4a,Me = 2.5 Hz,
1 H, 4a-H), 1.91 (m, 3 H, CH3) ppm. 13C NMR (75.5 MHz,
CDCl3): δ = 100.2 (C-5), 84.1 (C-3), 67.5 (C-2), 63.7 (NOCH3),
62.6 (C-1) ppm. IR (KBr): ν
= 3495, 3032, 2957, 2918, 2871,
˜
max
1554, 1454, 1378 cm–1. MS (EI): m/z (%) = 304 (2) [M]+. HRMS
(EI): calcd. for C15H16N2O5 [M]+ 304.1059; found 304.1054.
General Procedure for the Synthesis of Racemic N-Alkoxypiperid-
ines 6a–h: To a solution of 3a–d (1 mmol) in CH3CN (3 mL),
K2CO3 (1 mmol) was added, then 4a–c (1.1 mmol) was slowly
added dropwise. The reaction mixture was stirred at room temp.
for 4–9 h. Once the reaction was completed (reaction monitored by
TLC), the solvent was removed under reduced pressure and the
residue was suspended in CH2Cl2 and washed with water. The col-
lected organic layers were dried (MgSO4), concentrated, and the
residue was purified as described below to afford 6a–h.
(2R*,5S*,6R*)-1-Methoxy-2-methyl-5-nitro-6-phenylpiperidin-2-ol
(6a) and (2R*,3S*)-1-(Methoxy)-6-methyl-3-nitro-2-phenyl-1,2,3,4-
tetrahydropyridine (7a): Reaction time 6 h; purification by column
chromatography (EtOAc/hexane, 1:6); yield 229 mg, 86%; colorless
foam; 6a/7a ratio 96:4; Rf = 0.41 (EtOAc/hexane, 1:2). Data for 6a:
1H NMR (500 MHz, CDCl3): δ = 7.45–7.30 (m, 5 H, PhH), 4.75
(m, 1 H, 5-H), 4.53 (d, J5,6 = 10.4 Hz, 1 H, 6-H), 3.02 (s, 3 H,
OCH3), 2.94 (br. s, 1 H, OH), 2.49 (dtd, J4a,4e = 14.0, J4a,3a = 12.3,
J4a,5 = 12.3, J4a,3e = 4.2 Hz, 1 H, 4a-H), 2.08 (m, J4e,5 = 4.4, J4e,3a
= 4.4, J4e,3e = 3.0 Hz, 1 H, 4e-H), 2.05 (m, 1 H, 3e-H), 1.78 (m,
J3a,3e = 15.0 Hz, 1 H, 3a-H), 1.51 (s, 3 H, CH3) ppm. 13C NMR
(125.7 MHz, CDCl3): δ = 136.7, 128.6, 128.4, 128.4 (Ph), 88.4 (C-
5), 86.9 (C-2), 66.1 (C-6), 63.8 (OMe), 33.3 (C-3), 28.1 (Me), 25.5
(C-4) ppm. Data for 7a: 1H NMR (500 MHz, CDCl3): δ = 5.07 (td,
J3,4a = 9.2, J2,3 = 9.2, J3,4e = 5.7 Hz, 1 H, 3-H), 4.70 (m, 1 H, 5-
28.6 (CH ), 26.1 (C-4) ppm. IR (NaCl): ν
= 3504, 2942, 1731,
˜
3
max
1550, 1512, 1444, 1376, 1262 cm–1. MS (EI): m/z (%) = 326 (27)
[M]+. HRMS (EI) for 6c: calcd. for C15H22N2O6 [M]+ 326.1478;
found 326.1485.
(2R*,5S*,6R*)-1-(Benzyloxy)-6-(3,4-dimethoxyphenyl)-2-methyl-5-
nitropiperidin-2-ol (6d) and (2R*,3S*)-1-(Benzyloxy)-2-(3,4-dimeth-
oxyphenyl)-6-methyl-3-nitro-1,2,3,4-tetrahydropyridine (7d): Reac-
tion time 4 h; purification by column chromatography (EtOAc/hex-
ane, 1:5 Ǟ 1:1); yield 103 mg, 83%; colorless foam; 6d/7d ratio 96:4;
1
Rf = 0.28 (EtOAc/hexane, 1:2). Data for 6d: H NMR (300 MHz,
CDCl3): δ = 7.25–6.75 (m, 8 H, ArH, PhH), 4.83 (m, 1 H, 5-H),
4.56 (d, J5,6 = 10.4 Hz, 1 H, 6-H), 4.39, 3.87 (2ϫd, J = 8.9 Hz, 1
H each, CH2Ph), 3.89 (s, 6 H, 2ϫArOCH3), 2.92 (br. s, 1 H, OH),
2.51 (dtd, J4a,4e = 13.5, J4a,3a = 12.6, J4a,5 = 12.6, J4a,3e = 4.5 Hz,
1 H, 4a-H), 2.12 (m, 1 H, 4e-H), 2.06 (m, 1 H, 3e-H), 1.83 (m, 1
H, 3a-H), 1.61 (s, 3 H, CH3) ppm. 13C NMR (75.5 MHz, CDCl3):
δ = 149.5, 149.0, 129.0, 112.2, 111.0 (Ar), 135.5, 129.2, 128.5, 128.4
(Ph), 88.4 (C-5), 87.1 (C-2), 78.3 (CH2Ph), 66.0 (C-6), 56.1 (2ϫAr-
OCH3), 33.4 (C-3), 28.3 (CH3), 25.6 (C-4) ppm. Data for 7d: 1H
H), 4.65 (d, 1 H, 2-H), 2.80 (m, J4a,4e = 16.7, J4a,5 = 2.7, J4a,Me
=
2.3 Hz, 1 H, 4a-H), 1.92 (m, 3 H, CH3) ppm. 13C NMR
(125.7 MHz, CDCl3): δ = 100.0 (C-5), 83.8 (C-3), 67.6 (C-2), 63.5
(OMe), 28.2 (Me) ppm. IR (NaCl, Nujol): νmax = 3544, 3061, 2923,
˜
2815, 1738, 1557, 1455, 1374 cm–1. MS (EI): m/z (%) = 266 (8)
[M]+. HRMS (EI) for 6a: calcd. for C13H18N2O4 [M]+ 266.1267;
found 266.1270.
(2R*,5S*,6R*)-1-(Benzyloxy)-2-methyl-5-nitro-6-phenylpiperidin-2- NMR (300 MHz, CDCl3): δ = 5.13 (td, J3,4e = 5.8, J3,4a = 9.4, J3,2
ol (6b) and (2R*,3S*)-1-(Benzyloxy)-6-methyl-3-nitro-2-phenyl-
1,2,3,4-tetrahydropyridine (7b): Reaction time 5 h; purification by
column chromatography (EtOAc/hexane, 1:9); yield 264 mg, 78%;
white solid; m.p. 98–100 °C; 6b/7b ratio 97:3; Rf = 0.51 (EtOAc/
= 9.4 Hz, 1 H, 3-H), 4.61 (d, J2,3 = 9.4 Hz, 1 H, 2-H), 4.29, 4.17
(2ϫd, J = 9.6 Hz, 1 H each, CH2Ph), 2.80 (m, J4a,4e = 16.6, J4a,5
= 2.5, J4a,Me = 2.5 Hz, 1 H, 4a-H), 1.96 (m, 3 H, CH3) ppm. 13C
NMR (75.5 MHz, CDCl3): δ = 100.8 (C-5), 84.5 (C-3), 78.2
5486
www.eurjoc.org
© 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2010, 5482–5488